Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4081620

COc1ccc(N2CCN(c3nc(-c4ccccc4)c(CCC(=O)NS(=O)(=O)c4ccccc4)s3)CC2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.46
CETP P11597 1/20 0.44
ADORA3 P0DMS8 1/20 0.42
MAPT P10636 6/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
USP2 O75604 2/20 0.42
GAA P10253 3/20 0.42
LMNA P02545 2/20 0.42
ALOX15 P16050 1/20 0.42
MMP2 P08253 1/20 0.41
MMP13 P45452 1/20 0.41
NPSR1 Q6W5P4 3/20 0.41
ALDH1A1 P00352 2/20 0.41
HTT P42858 1/20 0.41
EGFR P00533 1/20 0.41
ERBB2 P04626 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL348313 0.95 GFER (0.50) GFERCETPADORA3MAPTSMN1; SMN2
SCHEMBL347639 0.87 EGFR (0.51) GFERCETPADORA3MAPTSMN1; SMN2
Trifluoroacetic Acid SCHEMBL4092194 0.84 AR (0.44) MAPTSMN1; SMN2GAALMNANPSR1
SCHEMBL348279 0.83 CETP (0.56) CETPADORA3MAPTUSP2GAA
SCHEMBL4081626 0.82 CETP (0.43) GFERCETPADORA3MAPTUSP2
SCHEMBL4081611 0.82 MAPT (0.59) CETPADORA3MAPTUSP2GAA
SCHEMBL4661535 0.78 NPSR1 (0.46) GFERCETPADORA3MAPTLMNA
SCHEMBL348219 0.78 AR (0.48) MAPTSMN1; SMN2GAANPSR1ALDH1A1
SCHEMBL347552 0.78 PTGDR2 (0.62) CETPADORA3MAPTUSP2GAA
Trifluoroacetic Acid SCHEMBL4090815 0.76 ALDH1A1 (0.46) CETPMAPTSMN1; SMN2GAANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090221604-A1 Thiazole Compounds and Their Use as PGD2 Antagonists ARGENTA DISCOVERY LIMITED (GB) 2009-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221604-A1 Thiazole Compounds and Their Use as PGD2 Antagonists PTGDR2, PTGDR, PTGER2 GFER 904/4885CETP 4678/4885ADORA3 417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.